Summary
The Gates Foundation plans to make weight-loss drugs more affordable for people in lower-income countries. They aim to reduce the costs of these drugs, which are currently expensive, to help tackle obesity and related health problems globally.
Key Facts
- The Gates Foundation wants to make weight-loss drugs cheaper and more accessible in lower-income countries.
- They focus on drugs like Wegovy and Mounjaro, which currently cost a lot.
- Semaglutide, the ingredient in Wegovy, will soon lose patent protection in some countries, allowing cheaper versions to be made.
- These drugs, called GLP-1 receptor agonists, help control appetite and were initially used for type 2 diabetes.
- The foundation may support clinical trials to understand the drugs' effects on different populations.
- Collaborations with organizations like the Pan American Health Organization might help reduce drug prices through bulk purchasing.
- Bill Gates stated that making these drugs affordable globally is a priority for the foundation.
